Activity of enoxaparin sodium in tuberculin syringes for 10 days

被引：8

作者：

Charland, SL

Davis, DD

Tillman, DJ

机构：

[1] Roche Labs, Nutley, NJ USA

[2] Univ Colorado, Denver, CO 80202 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1998年 / 55卷 / 12期

关键词：

D O I：

10.1093/ajhp/55.12.1296

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1296 / 1298

页数：3

共 11 条

[1] A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].

ANDERSON, FA ;

WHEELER, HB ;

GOLDBERG, RJ ;

HOSMER, DW ;

PATWARDHAN, NA ;

JOVANOVIC, B ;

FORCIER, A ;

DALEN, JE .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938

[2]

CHARLAND SL, 1997, PHARMACOTHERAPY, V17, P183

[3]

COOPER JF, 1971, J LAB CLIN MED, V78, P138

[4] Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home [J].

Koopman, MMW ;

Prandoni, P ;

Piovella, F ;

Ockelford, PA ;

Brandjes, DPM ;

vanderMeer, J ;

Gallus, AS ;

Simonneau, G ;

Chesterman, CH ;

Prins, MH ;

Bossuyt, PMM ;

deHaes, H ;

vandenBelt, AGM ;

Sagnard, L ;

DAzemar, P ;

Buller, HR .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :682-687

[5] Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis - An updated meta-analysis [J].

Leizorovicz, A .

DRUGS, 1996, 52 :30-37

[6]

LEVINE M, 1996, NEW ENGL J MED, V334, P667

[7] Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours [J].

Mewborn, AL ;

Kessler, JM ;

Joyner, KA .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (02) :167-169

[8] ASSAY OF HEPARIN IN PLASMA USING A CHROMOGENIC SUBSTRATE FOR ACTIVATED FACTOR-10 [J].

TEIEN, AN ;

LIE, M ;

ABILDGAARD, U .

THROMBOSIS RESEARCH, 1976, 8 (03) :413-416

[9] EVALUATION OF AN AMIDOLYTIC HEPARIN ASSAY METHOD - INCREASED SENSITIVITY BY ADDING PURIFIED ANTITHROMBIN-III [J].

TEIEN, AN ;

LIE, M .

THROMBOSIS RESEARCH, 1977, 10 (03) :399-410

[10]

1996, PHARM FORUM, V22, P3031

← 1 2 →